Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy. (Q54574751)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy. |
scientific article |
Statements
Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy. (English)
Tateki Yoshino
Hiroaki Shiina
Shinji Urakami
Nobuyuki Kikuno
Tatsuaki Yoneda
Kazushi Shigeno
Mikio Igawa
1 October 2006
12
20 Pt 1
6116-6124